TECH Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
5 results loaded, newest first. End of these results.
AbbVie Acquires Apogee
AbbVie acquires Apogee Therapeutics in a $10.9 billion cash deal, expanding its immunology pipeline
CRH Acquires Arcosa
CRH is acquiring Arcosa, a leading US provider of aggregates and critical infrastructure products, for $8.5 billion
ABBV Acquires APGE
AbbVie is acquiring Apogee for $135.11 per share in cash to expand its pipeline of clinical-stage candidates for inflammatory and immunological diseases
ABBV Acquires APGE
AbbVie is acquiring Apogee Therapeutics to deepen its immunology portfolio